![Antoine Barraud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Antoine Barraud
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Directeur Général | 01/01/2015 | - |
Fondateur | 01/01/2015 | - |
Historique de carrière de Antoine Barraud
Statistiques
Internationale
Suisse | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
AMF Medical SA
![]() AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Electronic Technology |
- Bourse
- Insiders
- Antoine Barraud
- Expérience